The Venous Thromboembolism Research Group is devoted to generating practice-changing knowledge in the areas of diagnosis, treatment and prevention of deep vein thrombosis and pulmonary embolism (venous thromboembolism-VTE). Collectively, the group currently runs 15 peer review-funded (e.g. CIHR, NIH, Heart & Stroke) or investigator-initiated studies on the diagnosis, prevention and treatment of thrombosis and 6 studies funded by various pharmaceutical companies. To date, the group has been awarded ~ $8 million funding as Principal Investigators and more than $26 million as Co-Investigators on peer-reviewed grants, and has led international thrombosis-related guideline development (e.g. ACCP guidelines, AHA guidelines, ASH guidelines) and knowledge transfer of evidence-based clinical practices with respect to thrombosis care and anticoagulation management.
Dr Vicky Tagalakis
Dr Tagalakis is a clinical epidemiologist and internist based at the Jewish General Hospital. She is appointed as Associate Professor in the Department of Medicine. She is Co-Lead of the Quality Improvement Platform of CanVECTOR, a CIHR funded Canadian national research and training network on venous thromboembolism (VTE).
Dr Tagalakis’ principal research interests focus primarily on etiologic mechanisms for VTE and VTE outcomes primarily in cancer patients. She has expertise in research methodology including pharmacoepidemiology pertaining to thrombosis-related analyses of large administrative databases. She has been awarded numerous peer-reviewed research grants from national and provincial funding agencies, and has published extensively in the field of venous thrombosis.
Visit her website: http://www.ladydavis.ca/en/vickytagalakis
Publications: View on PubMed
Dr Susan Kahn
Dr. Kahn is a clinical epidemiologist and internist based at the Jewish General Hospital in Montreal, where she is the founder and director of the Centre of Excellence in Thrombosis and Anticoagulation Care. She is appointed as Professor with Tenure in the Department of Medicine, McGill University, where she is Director of the McGill Thrombosis Fellowship. She is co-Director of the CIHR-funded CanVECTOR Network, a Canadian national venous thromboembolism research and training network.
Dr. Kahn’s research interests focus primarily on clinical trials of interventions to prevent, diagnose, treat, and improve outcomes of venous thromboembolism. She is internationally recognized for her research in the post-thrombotic syndrome. She holds a Tier 1 Canada Research Chair in Venous Thromboembolism, and previously held a National Clinical Research Scholar award from the Fonds de recherche du Québec-Santé (FRQ-S). She has been awarded numerous peer-reviewed research grants from national and provincial funding agencies, including a 7-year CIHR Foundation grant in 2015, and has published more than 200 papers in the field of thromboembolism. In 2016, she was elected to Fellowship in the Canadian Academy of Health Sciences (CAHS), considered one of the highest honors for members of the Canadian health sciences community. Also in 2016, she was awarded the Canadian Society of Internal Medicine (CSIM) Dr. David Sackett Senior Investigator Award. This award recognizes excellence in research by a senior Canadian general internist, and is intended to increase awareness of high-quality research by general internists in Canada and to foster such research.
Visit her website:http://www.ladydavis.ca/en/susankahn
Publications: View on PubMed